IRCT20220723055530N3已完成2 期
Evaluation of efficacy and safety of MediVim HA dermal fillers in correction of moderate-to-severe Nasolabial folds
ik Sina Eksir0 个研究点目标入组 33 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 65 years(—)
- 性别
- All
入选标准
- •30 -65 Years old men and women with moderate to severe nasolabial folds
- •Signing the informed consent form
排除标准
- •History of a cosmetic procedure in the lower 2/3 of the face during the last three months
- •Previous allergy to Hyaluronic Acid or Lidocaine
- •Presence of inflammation, active infection, unhealed old wound, and skin lesions in the NLF region
- •People prone to hypertrophic scar formation
- •History of autoimmune or immune deficiency diseases
- •Pregnancy or breastfeeding
研究者
相似试验
尚未招募
不适用
Safety and efficacy of skin care formulatioCTRI/2022/01/039134Kama Ayurveda Pvt Ltd
尚未招募
Unknown
Assessment of safety and efficacy of productCTRI/2024/03/064647BEAUTY GARAGE INDIA PVT. LTD.
尚未招募
不适用
Safety and efficacy of skincare formulatioCTRI/2022/01/039138Kama Ayurveda Pvt Ltd
尚未招募
Unknown
Effect of hair product on hair growth, dandruff and hair fallCTRI/2024/08/071942Emami Ltd.
尚未招募
2 期
A clinical study of a herbal formulation DRDC/2022/040 on symptoms of Gastroesophageal reflux disease (GERD)CTRI/2023/08/056221Dabur Research Development Centre Dabur India Limited
